
CMS slow to investigate PDP fraud
OIG report finds the Centers for Medicare & Medicaid Services was slow to respond to fraud allegations against prescription drug plans and lacked an antifraud strategy.
An investigation into antifraud and abuse measures for the Medicare Part D program by the HHS Office of Inspector General (OIG) found that in 2006, CMS relied primarily on complaints to identify
To see more Hot off the Press news articles,
To go to the Drug Topics homepage,





























































